EFL

Cohort Year: 2022-2023

Tracks: Life Sciences

VISIT WEBSITE

HDAX Therapeutics

HDAX Therapeutics is developing best-in-class therapeutics for neurological and cardiac diseases stemming from microtubule dysfunction.